Related Experiment Video
Updated: Jan 21, 2026

De Novo Generation of Somatic Stem Cells by YAP/TAZ
Published on: May 7, 2018
Molecular Mechanisms Associated with ROR1-Mediated Drug Resistance: Crosstalk with Hippo-YAP/TAZ and BMI-1 Pathways
Hanna Karvonen1,2, Harlan Barker1, Laura Kaleva1,2
1Faculty of Medicine and Health Technology, Tampere University, 33014 Tampere, Finland.
Abstract:
Signaling via the Wnt-related receptor tyrosine kinase-like orphan receptor 1 (ROR1) triggers tumorigenic features associated with cancer stem cells (CSCs) and epithelial-mesenchymal transition (EMT), while aberrant expression of ROR1 is strongly linked to advanced disease progression and chemoresistance. Several recent studies have shown that Wnt5a binding to ROR1 promotes oncogenic signaling by activating multiple pathways such as RhoA/Rac1 GTPases and PI3K/AKT, which in turn could induce transcriptional coactivator YAP/TAZ or polycomb complex protein BMI-1 signaling, respectively, to sustain stemness, metastasis and ultimately drug-resistance. These data point towards a new feedback loop during cancer development, linking Wnt5a-ROR1 signaling activation to YAP/TAZ or BMI-1 upregulation that could play an important role in disease progression and treatment resistance. This review focuses on the crosstalk between Wnt5a-ROR1 and YAP/TAZ or the BMI-1 signaling network, together with the current advancements in targeted strategies for ROR1-positive cancers.
Insights
Receptor tyrosine kinase-like orphan receptor 1 (ROR1) signaling drives cancer stemness and metastasis. Targeting the Wnt5a-ROR1 pathway may overcome drug resistance in ROR1-positive cancers.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Signaling
Background:
- Receptor tyrosine kinase-like orphan receptor 1 (ROR1) is implicated in cancer stem cell (CSC) and epithelial-mesenchymal transition (EMT) phenotypes.
- Aberrant ROR1 expression correlates with advanced disease, metastasis, and chemoresistance.
- Wnt5a binding to ROR1 activates oncogenic pathways, including RhoA/Rac1 and PI3K/AKT.
Purpose of the Study:
- To review the crosstalk between Wnt5a-ROR1 signaling and YAP/TAZ or BMI-1 networks in cancer.
- To discuss current targeted strategies for ROR1-positive cancers.
Main Methods:
- Literature review of studies on ROR1, Wnt5a, YAP/TAZ, BMI-1, CSCs, EMT, and targeted therapies.
- Analysis of signaling pathways involved in ROR1-mediated oncogenesis.
Main Results:
- Wnt5a-ROR1 signaling activates RhoA/Rac1 and PI3K/AKT pathways.
- These pathways can lead to the upregulation of YAP/TAZ or BMI-1, promoting stemness and metastasis.
- A feedback loop exists between Wnt5a-ROR1 and YAP/TAZ or BMI-1 signaling in cancer development.
Conclusions:
- The Wnt5a-ROR1 pathway, in conjunction with YAP/TAZ or BMI-1, plays a critical role in cancer progression and treatment resistance.
- Targeting ROR1 offers a promising therapeutic strategy for ROR1-positive cancers.
More Related Videos
07:16Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
Related Concept Videos
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
SN1 Reaction: Mechanism
Firstly, the haloalkane ionizes to generate a carbocation intermediate and a halide ion. This heterolytic cleavage is highly endothermic with large activation energy. The ionization of the substrate, facilitated by a...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antihypertensive Drugs: Action of β1 Blockers
Preparation of 1° Amines: Hofmann and Curtius Rearrangement Mechanism